OUR VALUES
OUR MISSION
Ozmosi was founded with the singular mission to provide pharmaceutical and biotechnology companies the support they need to make hard decisions in a high-risk and highly uncertain environment.
OUR DEDICATION
We are dedicated to providing pharmaceutical forecasting, data analysis and insights to support your strategic decision making, moving you from data, to insight, to confidence.
OUR COMMITMENT
When you hire Ozmosi, you’re not hiring just another consulting team with a set of standard report formats. Founder Beau Bush was a client before he was a consultant, so we understand what you need—and how you need it.
We’ll take the time to explore your specific business questions, and then assemble the tools to answer them from our disease area expert panels, industry benchmark libraries, and proprietary financial forecasting models.
OUR PROMISE
What’s more, our answers will come packaged in the formats you need, using the terms and financials you need to deliver results—including full profit-and-loss statements demonstrating the cumulative value impact of your product decisions.
The state-of-the-art software tools we use allow us to deliver complex analyses, including “what-if” scenarios, quickly and efficiently, so you always have the knowledge you need to respond to your dynamic market.
OUR TEAM
After more than a decade working on new product development, Beau left his position as Associate Director of Strategy and Portfolio Analysis at Janssen (Johnson & Johnson) in 2013, when he saw the opportunity to engage more directly with an increasingly complex and dynamic healthcare market.
With newly emerging business models and increasing complexity in drug development making it more and more difficult to predict the impact of new products—or decide which products to pursue—Beau envisioned a company that could bring clarity and confidence to the investment decisions that shape tomorrow’s pharmaceutical products.
Beau has a BS in biology from Rutgers University and has worked in several industries, including finance, pharmaceuticals, marine biology, environmental science, and business consulting. He brings to Ozmosi a deep understanding and broad knowledge of global market valuation and healthcare product development, as well as an extensive network of industry experts.
In his spare time at OZMOSI Michael leads Client Services projects too, such as pharmaceutical portfolio reviews, forecast tool development and company valuations for M&A analyses.
Michael earned his Master’s Degree in Business Administration from Salisbury University in Maryland. With this education, he brings a breadth of knowledge which is applied daily to OZMOSI’s various projects.
Sonam Gupta comes from a machine learning and natural language processing (NLP) background, along with a computer science foundation. She has a Master’s Degree in Information Systems with a focus on data analytics from Harrisburg University in Pennsylvania.
